Profil
Mr. Eric Song is a Research Analyst at Sio Capital Management LLC.
He is covering Therapeutics.
Prior to joining, he worked as a sell-side Research Associate covering biotechnology for Raymond James in 2017.
Prior to Raymond James, he worked as an independent investor applying value investing to biotech stocks.
Mr. Song earned his Ph.D in Molecular and Cellular Pharmacology from the University of Miami in 2014, He has undergraduate degree in Clinical Pharmacology from Shenyang Pharmaceutical University.
Aktive Positionen von Eric Song
| Unternehmen | Position | Beginn |
|---|---|---|
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital Management LLC (Sio Capital) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Michael Castor in 2006. Sio Capital provides discretionary investment advisory services to domestic and foreign private investment vehicles that are exempt from registration under the Investment Company Act of 1940 and separately managed accounts for institutions and large businesses. | Analyst-Equity | 01.01.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Sio Capital Management LLC
Sio Capital Management LLC Investment ManagersFinance Sio Capital Management LLC (Sio Capital) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Michael Castor in 2006. Sio Capital provides discretionary investment advisory services to domestic and foreign private investment vehicles that are exempt from registration under the Investment Company Act of 1940 and separately managed accounts for institutions and large businesses. | Finance |